Monopar Therapeutics Inc
NASDAQ:MNPR

Watchlist Manager
Monopar Therapeutics Inc Logo
Monopar Therapeutics Inc
NASDAQ:MNPR
Watchlist
Price: 74.605 USD -3.17% Market Closed
Market Cap: 498.4m USD

Wall Street
Price Targets

MNPR Price Targets Summary
Monopar Therapeutics Inc

Wall Street analysts forecast MNPR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MNPR is 114.005 USD with a low forecast of 93.93 USD and a high forecast of 136.5 USD.

Lowest
Price Target
93.93 USD
26% Upside
Average
Price Target
114.005 USD
53% Upside
Highest
Price Target
136.5 USD
83% Upside
Monopar Therapeutics Inc Competitors:
Price Targets
CHRS
Coherus BioSciences Inc
278% Upside
DTIL
Precision BioSciences Inc
564% Upside
688366
Shanghai Haohai Biological Technology Co Ltd
59% Upside
2157
Lepu Biopharma Co Ltd
98% Upside
RYTM
Rhythm Pharmaceuticals Inc
13% Upside
196170
Alteogen Inc
25% Upside
PHM
Pharma Mar SA
32% Upside
ALCLS
Cellectis SA
61% Upside

Revenue
Forecast

Revenue Estimate
Monopar Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Monopar Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Monopar Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-63%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MNPR's stock price target?
Price Target
114.005 USD

According to Wall Street analysts, the average 1-year price target for MNPR is 114.005 USD with a low forecast of 93.93 USD and a high forecast of 136.5 USD.

Back to Top